Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
2576
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.12M | ﹤0.01% |
+66,231
| New | +$1.96M |
|
2577
PUT
Ionis Pharmaceuticals
IONS
$9.04B
| $2.12M | ﹤0.01% |
54,300
-252,200
| -82% | -$8.99M |
|
|
WW
2578
PUT
DELISTED
WW International
WW
| $2.12M | ﹤0.01% |
66,200
-9,200
| -12% | -$321K |
|
|
BNY
2579
CALL
Bank of New York Mellon
BNY
$108B
| $2.12M | ﹤0.01% |
62,200
+7,000
| +13% | +$228K |
|
|
NPSP
2580
PUT
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $2.12M | ﹤0.01% |
70,500
+26,100
| +59% | +$719K |
|
|
LGF
2581
PUT
DELISTED
Lions Gate Entertainment
LGF
| $2.11M | ﹤0.01% |
68,200
+5,700
| +9% | +$188K |
|
2582
CALL
BioMarin Pharmaceuticals
BMRN
$11.7B
| $2.11M | ﹤0.01% |
30,100
+10,600
| +54% | +$720K |
|
|
AXE
2583
DELISTED
Anixter International Inc
AXE
| $2.11M | ﹤0.01% |
23,646
-9,080
| -28% | -$790K |
|
2584
CALL
DaVita
DVA
$11.9B
| $2.1M | ﹤0.01% |
33,300
+4,700
| +16% | +$276K |
|
|
GAP
2585
CALL
The Gap Inc
GAP
$7.48B
| $2.1M | ﹤0.01% |
53,800
-38,500
| -42% | -$1.51M |
|
2586
CALL
Quest Diagnostics
DGX
$26B
| $2.09M | ﹤0.01% |
39,500
+3,200
| +9% | +$190K |
|
2587
CALL
Check Point Software Technologies
CHKP
$12.7B
| $2.09M | ﹤0.01% |
32,700
-600
| -2% | -$36.1K |
|
|
KCG
2588
DELISTED
KCG Holdings, Inc.
KCG
| $2.08M | ﹤0.01% |
189,527
+16,174
| +9% | +$164K |
|
2589
Penske Automotive Group
PAG
$14.3B
| $2.08M | ﹤0.01% |
44,348
+16,457
| +59% | +$703K |
|
|
OUTR
2590
CALL
DELISTED
OUTERWALL INC
OUTR
| $2.08M | ﹤0.01% |
31,100
-17,400
| -36% | -$1.13M |
|
2591
Cheesecake Factory
CAKE
$5.3B
| $2.08M | ﹤0.01% |
43,396
+11,497
| +36% | +$538K |
|
2592
CALL
Nasdaq
NDAQ
$53.3B
| $2.08M | ﹤0.01% |
160,200
+80,400
| +101% | +$983K |
|
|
IRF
2593
DELISTED
INTL RECTIFIER CORP
IRF
| $2.08M | ﹤0.01% |
80,083
+26,697
| +50% | +$650K |
|
2594
CALL
AngloGold Ashanti
AU
$44.5B
| $2.08M | ﹤0.01% |
189,200
+76,600
| +68% | +$1.04M |
|
2595
PUT
Incyte
INCY
$24.5B
| $2.08M | ﹤0.01% |
41,600
-112,800
| -73% | -$4.91M |
|
2596
PUT
Vanguard Real Estate ETF
VNQ
$38.9B
| $2.08M | ﹤0.01% |
32,500
+9,000
| +38% | +$602K |
|
|
PETM
2597
PUT
DELISTED
PETSMART INC
PETM
| $2.07M | ﹤0.01% |
28,800
-1,000
| -3% | -$73.2K |
|
|
HRC
2598
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.07M | ﹤0.01% |
50,484
+7,358
| +17% | +$295K |
|
|
ITG
2599
DELISTED
Investment Technology Group Inc
ITG
| $2.07M | ﹤0.01% |
103,325
+12,956
| +14% | +$234K |
|
|
S
2600
PUT
DELISTED
Sprint Corporation
S
| $2.06M | ﹤0.01% |
206,250
-185,020
| -47% | -$1.39M |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.